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UTI. Controls were randomly selected 
subjects who visited their general 
practitioner for reasons other than UTI or 
fever. A validated pelvic floor questionnaire 
(the Pelvic Floor Inventories Leiden, PelFIs) 




Between October 2006 and December 2007, 
153 cases were included; of these, the 
completed questionnaires of 102 (response 
rate 67%) were compared to those of 100 of 
110 (response rate 91%) controls. The 
median age of cases and controls was 65 and 
58 years, respectively; 40% of cases and 
controls were men. The percentage of PelFIs 
outcomes consistent with PFD were 
comparable between cases and controls, at 
21% vs 23%, respectively (odds ratio 0.9, 
95% confidence interval, CI, 0.4–1.78). In the 
multivariate analysis, comorbidity (odds 
ratio 4.9, 95% CI 2.2–11.1) and a history of 
UTI (odds ratio 2.5, 95% CI 1.0–6.1) were 
independent significant risk factors for 
febrile UTI, whereas PFD was not (odds ratio 
1.0, 0.5–2.2). Within the group of cases, PFD 
was not associated with bacteriuria during 
assessment of PelFIs (odds ratio 1.1, 95% CI 
0.4–3.5) and inversely related to a history of 





PFD is common among adults but it does not 
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To determine whether pelvic floor 
dysfunction (PFD) might be a risk factor for 
or consequence of febrile urinary tract 
infection (UTI), as UTI in adults is a common 
infection in which an underlying urological 
abnormality is often considered, and as in 
children, PFD is also thought to have a 




A multicentre case-control study was 
conducted at 26 primary-care centres and at 
six Emergency Departments of regional 









UTIs are among the most common bacterial 
infections in humans and there is ample 
knowledge about its management. Fever 
in UTI suggests the presence of acute 
pyelonephritis that causes substantial 
morbidity and mortality, with estimated direct 
and indirect costs of $2.14 billion in the USA 
in 2000 [1–3].
For the pathophysiology of UTIs, in the past 
decades there has been successful molecular 
research that has unravelled the main 
determinants of bacterial virulence and 
overall host resistance [4–9]. However, the 
significance of these molecular findings for 
individual patient management remains 
unclear, and purposeful integration into 
clinical practice guidelines has not been 
straightforward. In clinical practice, a 
diagnostic urological evaluation is considered 
after complicated or recurrent UTIs and 
strongly recommended if underlying 
urological disorders are suspected, especially 
in men and postmenopausal women [10–13]. 
In general, a urological evaluation relies on a 
thorough search for anatomical or functional 
disorders but the yield for detecting new 
abnormalities is rather low [14,15].
Pelvic floor dysfunction (PFD) is a general 
term for functional clinical problems affecting 
urinary, rectal and/or sexual function [16]. In 
children, PFD, also termed dysfunctional 
voiding or dysfunctional elimination 
syndrome, is widely accepted as a major 
contributor to the development of UTIs, and 
pelvic muscle floor rehabilitation is the 
standard of treatment for many young 
patients [17]. It has been suggested that 
PFD might also explain the occurrence of 
complicated UTIs in cases with a normal 
urinary tract [18]. However, in adults the role 
of PFD in UTIs has only been described in 
selected subgroups, predominantly young 
women with recurrent UTIs [19–22]. To our 
knowledge there have been no comparative 
studies that assessed the question of 
whether PFD is a risk factor in adults with 
complicated UTI.
For this reason, we conducted a case-control 
study of community-acquired febrile UTI in an 
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unselected population. The aim of the study 
was to determine whether PFD might be a risk 
factor for or consequence of febrile UTI. A 
validated questionnaire, the Pelvic Floor 
Inventories Leiden (PelFIs), including 
questions about micturition, defecation and 





We conducted a multicentre case-control 
study; cases were recruited at six emergency 
departments of regional hospitals and 26 
neighbouring primary healthcare centres. 
Consecutive patients (men and women) 
presenting with a presumptive diagnosis of 
febrile UTI, and those who met the following 
entry criteria and provided written informed 
consent, were included.












C) and/or a history of fever and chills 
within 24 h before presentation, at least one 
symptom of UTI (dysuria, frequency, urgency 
and suprapubic, perineal or flank pain) and 
leukocyturia defined as a positive leukocyte 
esterase dipstick test or the presence of more 
than five leukocytes per high-power field in a 
centrifuged sediment.




18 years who consulted their primary 
healthcare physician for reasons other than 
fever or UTI. They were recruited at random 
selected dates at primary healthcare centres 
within the same region as recruitment of 
cases.
Exclusion criteria at presentation with febrile 
UTI were polycystic kidney disease, haemo- 
or peritoneal dialysis, a history of kidney 
transplantation or an expected inability to 
obtain follow-up (e.g. language barrier). As for 
cases, the PelFIs was obtained 28–32 days 
after presentation with a febrile UTI, and the 
following exclusion criteria were applied: 
patients with indwelling urinary catheter, 
urostomy, recent pelvic surgery, spinal cord 
lesions or those who developed cognitive 
dysfunction or became pregnant. For controls, 
all of the above exclusion criteria also applied. 
The study was approved by the local ethics 
committees (protocol number P06.061).
Baseline demographic, clinical and 
microbiological data were collected by 
certified research nurses or the clinical 
investigators (C.v.N., A.v.L.) who visited 
all primary-care patients directly after 
notification. Data from patients included at 
the emergency departments were collected 
from the medical record, completed with an 
interview by telephone or at the bedside.
Blood and urine cultures were taken before 
starting antimicrobial therapy within 2 h 
of notification, and were assessed using 
standard microbiological methods. Cases 
were treated for 10–14 days with 
antimicrobials for febrile UTI. Cases were 
visited 28–32 days after presentation with 
febrile UTI to assess the clinical and 
microbiological outcome. A midstream urine 
specimen was cultured and all cases were 
asked to complete the PelFIs. Controls were 
visited once after notification to collect 
demographic and microbiological data, 
including urine cultures, and to complete the 
PelFIs.
All questionnaires were evaluated 
independently by two urologists (H.W.E., 
R.C.M.P.) who were unaware of all other data 
except for gender. They dichotomized the 
outcomes of the questionnaires to either 
suspected presence or absence of PFD. The 
cases with interobserver disagreement were 
re-evaluated and discussed by these two 
urologists, who adjudicated the final outcome 
based on their consensus. Examples of 
questions of the PelFIs are listed in the 
Appendix.
Comorbidity was defined as the presence of 
any urinary tract disorder, heart failure, 
cerebrovascular disease, renal insufficiency, 
diabetes mellitus, malignancy or chronic 
obstructive pulmonary disease for which the 
patient is prescribed medication and/or 
consults a hospital-based medical specialist.
Urinary tract disorder was defined as any 
history of anatomical urological abnormality 
(e.g. BPH, nephrectomy, re-implantation of 
ureter, VUR, bladder carcinoma, urethral 
stricture) except nephrolithiasis. Significant 








 colony-forming units/mL of urine [24].
Descriptive analysis included means or 
percentages with 95% CIs, or the median 
(range), as appropriate. Inter-observer 
agreement for the accurate determination of 
the presence or absence of PFD was assessed 









of 0.41–0.60 corresponds to fair agreement, 
0.61–0.80 to good agreement, 0.81–0.92 to 
very good agreement and 0.93–1.00 to 
excellent agreement [25]. For comparison of 
cases and controls, we used multivariable 
logistic regression to calculate the odds ratios 
(ORs) with their 95% CIs for categorical 
variables. In addition to age and sex we 
adjusted for comorbidity and a history of UTIs 
as potential confounders. This included the 
evaluation of potential interaction terms 
between these factors. Finally, within the 
group of cases, those with suspected PFD 
were compared to those without using 
chi-square tests to assess univariable 
associations. Multivariable analysis for this 
subgroup analysis was not done because of 














Between October 2006 and October 2007, 178 
patients with febrile UTI were enrolled in the 
study and 153 met the criteria for case 
definition. Of these 153 cases, 51 could not be 
evaluated because they were lost to follow-
up, died, refused or for other reasons (Fig. 1). 
The remaining 102 cases (response rate 67%) 
were compared to the 51 excluded cases; 
there were no differences with respect to 
gender, diabetes mellitus or history of UTIs, 
but the excluded cases were older (median 








 0.002) and they had 
an underlying urinary tract disorder more 








 0.013). The PelFIs 
questionnaires were analysed and compared 
to those of the 100 controls of 110 asked 
(response rate 91%). Most controls consulted 
their primary healthcare physician because 
of cardiovascular risk management or 
musculoskeletal symptoms. The median age 
of cases and controls was 66 and 58 years, 
respectively; 60% were women. Cases were 
more likely to have comorbidity, urological 
disorders, a history of UTIs and bacteriuria 
during completion of the questionnaire 
(Table 1).
Besides fever and symptoms of UTI at 
presentation with febrile UTI, 62% of cases 
noticed flank pain, 66% had shaking chills and 
28% were pre-treated for UTI. Cases were 
empirically treated with oral ciprofloxacin as 
outpatients in 39%, while the remaining 61% 
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Urine samples, cultured at presentation with 
febrile UTI, were available in 98 cases; 66 




). Of the remaining 32 cases 
without significant bacteriuria, 17 could be 
explained by antimicrobial pretreatment. 
Blood cultures were available in 98 cases; 17 





After recovery of febrile UTI, in 98 cases 
a repeat urinary culture was available 
28–32 days after the initial presentation with 
febrile UTI. Of these, 22 (22%) revealed 




). One of 
these 22 cases had recurrent UTI symptoms; 
the remaining 21 with bacteriuria were 
considered asymptomatic.
The interobserver agreement between the 
two urologists for interpreting the PelFIs 
















 0.001). The presence of PFD, as assessed 
by the PelFIs questionnaire, was lower among 
cases than controls but this was not 
statistically significant, at 21% vs 23%, 
respectively (OR 0.9, 95% CI 0.4–1.7). This OR 
was the same after adjusting for age and sex. 
As this could be different for men and women 
we compared the 62 women with the 62 
women controls; the OR for PFD associated 
with febrile UTI, was 0.7 (95% CI 0.3–1.6).
Other risk factors for the presence of febrile 
UTI were comorbidity, urinary tract disorders 
and previous UTIs (Table 2). Independent 
significant risk factors for febrile UTI in the 
multivariable analysis were comorbidity (OR 
4.9, 95% CI 2.2–11.1), a history of UTI (OR 2.5, 
95% CI 1.0–6.1) and a history of UTI the 
previous year (OR 3.0, 95% CI 1.1–8.2).
Among the 102 cases, a history of urinary 
tract disorder, which was present 
predominantly in men, was associated with 
the presence of PFD (OR 3.7, 95% CI 1.1–12.1, 




75 years and 
a history of UTI within the previous year were 
both inversely associated (0.3, 0.06–1.2; and 
0.2, 0.1–0.9, respectively). The presence of 
bacteriuria during assessment of the PelFIs 
(OR 1.1, 95% CI 0.4–3.5) was not associated 




To our knowledge, the present study is the 
first to investigate the relationship between 
PFD and febrile UTI in adults which, in this 
study setting, might also be interpreted as 
acute pyelonephritis [2,3]. We found that PFD 
is common but seems to be neither a risk 
factor for nor a consequence of febrile UTI in 
adults. In patients who recovered from febrile 
UTI, 21% were suspected to have PFD, 
compared to 23% in a general adult 
population seeking primary healthcare. As this 
was assessed shortly after recovery from a 
febrile UTI, we conclude that PFD also does 
not seem to be a consequence of febrile UTI.
To assess the presence of PFD we used a 
previously validated questionnaire, the PelFIs, 
which is not the reference standard to detect 
PFD [23]. However, if there were any standard 
to assess PFD, the diagnostics used would be 
complex and often require multiple, difficult 
to interpret, confirmatory tests [26]. In our 
experience, based on this questionnaire, 
patients can be stratified into those suspected 
not suspected to have PFD. Suspected cases 
are subjected to further analysis of the pelvic 




Enrolment of participants in the
study.
25 Had an exclusion criterion
  11 indwelling urinary catheter
  8 cognitive dysfunction
  3 spinal cord injury
  1 urostomy
  1 underwent urological surgery
  1 pregnancy
10 Excluded
  10 no response  
110 Controls included




  7 died
  15 lost to follow-up
  8 reason unknown
21 Other reasons
  10 refused participation
  6 no response
  5 incomplete questionnaire
178 Consecutive patients with febrile UTI
     79 men
     99 women  
102 Cases
  40 men
  62 women 
100 Controls
   39 men
  61 women 
153 Cases did meet inclusion




The baseline characteristics of the 102 cases and 100 controls
 
Characteristic Cases Controls
Median (interquartile range) age, years 65 (44–75) 58 (48–67)









25 (4) 26 (4)
Smoking 17 (17) 14 (14)
Comorbidity:
Diabetes mellitus 19 (19) 8 (8)
Urinary tract disorder 18 (18) 10 (10)
History of UTIs 51 (50) 21 (21)
Bacteriuria during PelFIs 23/98* (24) 4 (4)
 




 (%) unless otherwise indicated.
 
V A N  N I E U W K O O P  
 






2 0 0 9  T H E  A U T H O R S
 
1 6 9 2
 




 2 0 0 9  B J U  I N T E R N A T I O N A L
 
of these cases [27]. We therefore conclude the 
PelFIs is a useful tool for such a case-control 
study, as is also illustrated by the high degree 
of interobserver agreement in the present 
study.
The strengths of our study are the inclusion of 
cases reflecting daily practice within the 
community setting of patients presenting 
with febrile UTI or acute pyelonephritis, and 
controls reflecting the same community of 
people seeking medical attention, reflecting 
daily primary healthcare practice. 
Furthermore, all subjects were clinically and 
microbiologically well documented, with 
almost no missing data. The combination of 
pelvic floor assessment and urine cultures 
especially created robust data to support the 
above conclusions.
The limitations of our study are its relatively 
small sample size and the possibility of 
selection and recall bias. For sample size, it 
could therefore not be excluded that in 
specific subgroups there might indeed be a 
relationship between febrile UTI and PFD. 
However, the data are consistent with 
previous reports on other risk factors for 
pyelonephritis and UTIs in general. In this 
respect, selection bias is unlikely. We selected 
cases with febrile UTI for assessment of pelvic 
floor function only if this would have made 
sense clinically. Therefore patients with, for 
instance, an indwelling urinary catheter, were 
excluded, as was also done in the control 
group. In daily practice a similar selection 
would occur before considering a pelvic floor 
assessment. The response rate in the group of 
cases was lower than in the control group 
(67% vs 91%) and cases excluded on pre-set 
exclusion criteria were older and more often 
had an underlying urinary tract disorder. This 
raises concern that selection bias in the group 
of cases might have skewed the findings. We 
therefore evaluated the group on risk factors 
for PFD and found a positive association with 
underlying urinary tract disorder and a 
negative association with older age (point 
estimate of the OR 3.6 and 0.3, respectively). 
The net outcome of these contradictory 
associations is uncertain, but it is reasonable 
to consider these effects as balanced. Hence, 
it is unlikely that we selectively excluded cases 
with PFD, as described in Fig. 1. However, 
residual selection bias cannot be excluded 
with certainty.
We used a case-control study design and this 
approach holds a risk of recall bias. In our 
setting, cases completed the PelFIs after a 
diagnosis of febrile UTI, which might have 
enhanced the sensitivity in reporting 
symptoms of PFD. However, the severity of 
febrile UTI and the fact that cases were 
slightly older and more frequently had 
underlying comorbidity, might have clouded 
their memory, leading to reduced sensitivity in 
detecting PFD; again, the net effect is unclear 
but presumably neutral.
Controls were individuals seeking primary 
healthcare and 23% (28% in women and 18% 
in men) of them were suspected to have PFD. 
This might also be a biased selection of the 
general healthy population, but the reasons 
for seeking medical care were unlikely to be 
associated with PFD. Moreover, based on 
symptoms assessed by interviews, as in our 
study, a large recent population study in 
women estimated the prevalence of PFD to be 
24%, which is similar to our estimate of 28% 
in women [28].
The risk factors we identified for febrile UTI 
or pyelonephritis were remarkably similar 
to previous reports of risk factors for 
pyelonephritis and UTIs [11,29–31]. 
Underlying comorbidity, especially urinary 
tract disorders and diabetes mellitus, and a 
history of UTI were associated with febrile 
UTI. Known risk factors like recent sexual 
intercourse, new sexual partner or use of 
spermicide, could not be assessed because 
these data were not collected [29]. Urinary 
incontinence or difficulty holding urine are 
associated with febrile UTI but, as this was 
part of the PelFIs questionnaire, these risk 
factors were not analysed separately [11,29].
Risk factors for the presence of PFD in adults 
could not be addressed by this study because 
there were too few cases with suspected 
PFD. Nevertheless, our results suggest a 
relationship with an underlying urinary 
tract disorder. In this study population, 
an underlying urinary tract disorder 
predominantly occurred in men, in particular 
BPH. A possible explanation for the 
relationship between PFD and urinary tract 
disorder might therefore be that the LUTS 



















Adjusted for age, sex,
comorbidity and history of UTI






50 years 72 (71) 69 (69) 1.1 (0.6–2.0) 1.1 (0.6–2.0)* 0.8 (0.4–1.7); 0.58
Men 40 (39) 39 (39) 1.0 (0.6–1.8) 0.9 (0.5–1.7)† 1.5 (0.7–3.2); 0.25
Comorbidity





Urinary tract disorder 18 (18) 10 (10) 1.9 (0.8–4.4) 1.9 (0.8–4.5) 0.6 (0.2–1.8); 0.39
Diabetes mellitus 19 (19) 8 (8) 2.6 (1.1–6.3) 2.4 (0.9–5.9) 1.9 (0.7–5.2); 0.20
History of UTI
Any previous UTI 51 (50) 21 (21) 3.8 (2.0–7.0) 5.0 (2.5–10.1) 2.5 (1.0–6.1); 0.04
History of UTI previous year 35 (35)‡ 11 (11) 4.4 (2.1–9.2) 5.4 (2.4–12.1) 3.0 (1.1–8.2); 0.04
 
Data are presented as n (%). *adjusted for sex; †adjusted for age; ‡two missing values.
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autonomic nervous system overactivity, and 
similar symptoms are listed in the PelFIs 
questionnaire that particularly predicts PFD in 
terms of overactive rest tone [27,32].
Furthermore there was an inverse relationship 
between a history of UTI and PFD, whereas 
there was no association with asymptomatic 
bacteriuria. This strongly suggests that there 
is either no or an inverse relationship between 
UTIs and PFD in adults. This finding is rather 
counterintuitive because UTIs are one of the 
key features of dysfunctional voiding in 
children and so far, reports suggest that this is 
also true for adults [17,21,22]. Probably, as the 
PelFIs questionnaire addresses three different 
domains of the pelvic floor, related to 
micturition, defecation and sexual function, 
the PFD noted in this cohort could have relied 
upon problems concerning defecation and 
sexual function, of which the latter might lead 
to sexual abstinence and thus a lower chance 
of developing UTIs [29]. Future studies are 
needed to address this issue further. Another 
explanation for the apparent discrepancy 
between children and adults for UTIs and PFD 
is that the studies in children are biased by 
selection, by which only children with 
recurrent UTI were referred to paediatric 
urologists and thus included in the studies on 
dysfunctional voiding. This issue is illustrated 
by the fact that in a general paediatric 
population with UTI there was no relation 
with the dysfunctional elimination syndrome 
[33]. Furthermore, in the largest cohort 
ever described of children referred to the 
paediatric urology service, the association 
between UTI and the dysfunctional 
elimination syndrome could only be shown in 
the subgroup of children with concurrent VUR 
[34,35]. In this respect, the results of the 
present study also suggest that PFD in the 
general population is not related to febrile 
UTI. Further studies are needed to evaluate 
whether this is also true for the subgroup of 
adults with an underlying urinary tract 
disorder, and in men with BPH in particular. 
However, VUR is a problem of the developing 
child, i.e. children are different from adults.
In summary, we showed that PFD is common 
in adults seeking healthcare but it does not 
seem to have a pathophysiological role in 
febrile UTI or acute pyelonephritis. These 
findings contradict the general belief that PFD 
is a considerable cause of complicated UTI in 
adults. This might have implications for future 
research on this topic, in particular the 
question of whether this is also true for 
specific subgroups of patients with 
underlying urinary tract disorder, and the 
development of guidelines for urological 
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APPENDIX
The PelFIs is a validated questionnaire 
developed to evaluate whether pelvic floor 
dysfunction should be suspected. The 
contents of this questionnaire can be divided 
into several domains regarding pelvic floor 
function that is micturition, defecation and 
sexual function. Within the following out of 
each specific domain sample questions of the 
PelFIs are listed.
Domain micturition
How often on average do you urinate during 
the day?
2–4 × per day; 5–7 × per day; 8–10 × per day; 
more than 10 × per day
How often on average do you urinate at night?
never; 1–2 × per night; 3–4 × per night; 
>4 × per night
How often do you feel the need to urinate?
continually; every half hour; every hour; 
longer than 1 h; 2–4 h; Longer
Can you put off urinating if you are sitting 
quietly?
must run directly; for a few minutes; have 
good control; other. Please indicate:
Does the urine come in one spurt?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Do you have to push when you urinate?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Domain urinary continence
Are you ever incontinent?
yes; no
How much urine leaks?
drops; a small burst; a whole bladderful; 
other. Please indicate: ; not applicable
Do you have more leakage:
in the cold, yes, no; if a tap is running, yes, no; 
if you are nervous, yes, no; in the shower, 
yes, no
Domain obstructive micturition
Do you have the feeling after urinating that 
the bladder is completely empty?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Is urinating itself painful?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
When you have finished urinating and stand 
up, does it still dribble?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Domain defecation
How often on average per week do you have 
bowel movement in the daytime?
<1 × per week; 1–2 × per week; 3–7 × per 
week; >7 × per week; never; other. Please 
indicate:
What is the consistency of the stool?
thin, watery; mushy; soft; hard; varying 
consistency; other. Please indicate:
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Do you ever have bright red bleeding during 
the bowel movement?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Domain fecal incontinence
Do you ever have bowel incontinence?
yes; no
Can you put off the urge to empty your bowel 
for 15 min?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Do you feel that faeces is leaking?
yes; no; sometimes; not applicable
Have you ever had skin irritation around the 
anus?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Have you ever had itch around the anus?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Domain constipation
Whenever you go to the toilet to move your 
bowels, do you need more than 15 min for 
this?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Do you feel that the bowel is completely 
empty after the bowel movement?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Do you feel that the stool is coming in pieces 
(several times consecutively)?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Do you have pain around the anus after a 
bowel movement?
never; seldom; sometimes; regularly; always; 
other. Please indicate:
Domain sexual function
Do you have sexual intercourse?
yes; no
Do you have pain during intercourse?
pain on penetration, yes, no, not applicable; 
pain deep inside; yes, no, not applicable
In addition to the above listed sample 
questions the PelFIs includes specific 
questions for men and women. For men there 
are additional questions about erectile 
function and for women questions related to 
vaginal prolapse, menstrual cycle and history 
of pregnancies and deliveries.
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